CompletedPhase 2NCT00947960
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease
Studying Adult polyglucosan body disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baylor Research Institute
- Principal Investigator
- Raphael Schiffmann, M.D, M.H.ScInstitute of Metabolic Disease
- Intervention
- Triheptanoin(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2009 – 2015
Study locations (1)
- Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Collaborators
Ultragenyx Pharmaceutical Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00947960 on ClinicalTrials.govOther trials for Adult polyglucosan body disease
Additional recruiting or active studies for the same condition.